A549 |
Growth Inhibition Assay |
5 nM |
24/48/72 h |
inhibits cell growth time-dependently |
22106282 |
LNCaP |
Growth Inhibition Assay |
5 nM |
24/48/72 h |
inhibits cell growth time-dependently |
22106282 |
HFS |
Growth Inhibition Assay |
5 nM |
24/48/72 h |
inhibits cell growth time-dependently |
22106282 |
CO115 |
Growth Inhibition Assay |
5 nM-50 μM |
24 h |
inhibits cell growth in a concentration-dependent manner |
22924958 |
RKO |
Growth Inhibition Assay |
5 nM-50 μM |
24 h |
inhibits cell growth in a concentration-dependent manner |
22924958 |
HCT116 |
Growth Inhibition Assay |
5 nM-50 μM |
24 h |
inhibits cell growth in a concentration-dependent manner |
22924958 |
NCI/ADR-RES |
Growth Inhibition Assay |
1–20nM |
72 h |
reduces cell viability alone and combined with cisplatin |
23010348 |
OVCAR-8? |
Growth Inhibition Assay |
1–20nM |
72 h |
reduces cell viability alone and combined with cisplatin |
23010348 |
Brca1 Null |
Growth Inhibition Assay |
1–20nM |
72 h |
reduces cell viability alone and combined with cisplatin |
23010348 |
Brca1 WT |
Growth Inhibition Assay |
1–20nM |
72 h |
reduces cell viability alone and combined with cisplatin |
23010348 |
SKOV-3 |
Growth Inhibition Assay |
1–20nM |
72 h |
reduces cell viability alone and combined with cisplatin |
23010348 |
DpP75? |
Apoptosis Assay |
1/10/100 nM |
48 h |
induces blunt apoptosis |
23532732 |
DpVp50 |
Apoptosis Assay |
1/10/100 nM |
48 h |
induces blunt apoptosis |
23532732 |
DpVp35 |
Apoptosis Assay |
1/10/100 nM |
48 h |
induces blunt apoptosis |
23532732 |
HuT78 |
Apoptosis Assay |
1/10/100 nM |
48 h |
induces apoptosis at 1 nM |
23532732 |
A549 |
Growth Inhibition Assay |
10–100?nM |
24/36/48 h |
inhibits cell growth in both concentration- and time-dependent manner |
24485799 |
MS-275 |
Growth Inhibition Assay |
0.625-10nM |
48 h |
induces a significantly stronger inhibition of cell proliferation co-treated with bortezomib |
24771510 |
HA |
Growth Inhibition Assay |
0.625-10nM |
48 h |
induces a significantly stronger inhibition of cell proliferation co-treated with bortezomib |
24771510 |
ACH-2 |
Function Assay |
1-9 nM |
24 h |
induces HIV-1 Env expression |
25149467 |
HCT116 |
Growth Inhibition Assay |
5-5000 nM |
24 h |
induces cell death in a concentration-dependent manner |
25492515 |
U2932/EBV |
Cell Viability Assay |
2.5-15 nM |
72 h |
induces cytotoxicity in a concentration-dependent manner? |
25790907 |
LY7/EBV |
Cell Viability Assay |
2.5-15 nM |
72 h |
induces cytotoxicity in a concentration-dependent manner? |
25790907 |
Farage |
Cell Viability Assay |
2.5-15 nM |
72 h |
induces cytotoxicity in a concentration-dependent manner? |
25790907 |
OCI-LY7 |
Cell Viability Assay |
2.5-15 nM |
72 h |
induces cytotoxicity in a concentration-dependent manner? |
25790907 |
U2932? |
Cell Viability Assay |
2.5-15 nM |
72 h |
induces cytotoxicity in a concentration-dependent manner? |
25790907 |
SU-DHL4 |
Cell Viability Assay |
2.5-15 nM |
72 h |
induces cytotoxicity in a concentration-dependent manner? |
25790907 |
THJ-16T |
Growth Inhibition Assay |
1 nM |
24 h |
inhibits cell growth |
20810568 |
HCT116 |
Function Assay |
20 nM |
8 h |
modulates transcript levels for hundreds of genes in either direction |
20739454 |
B104? |
Function Assay |
2 nM |
24/48/72 h |
increases the surface expression of CD20? |
20686505 |
HL-60? |
Cytotoxicity Assay |
1-500 nM |
24 h |
induces cytotoxicity in a concentration-dependent manner? |
20624163 |
HP100 |
Cytotoxicity Assay |
1-500 nM |
24 h |
induces cytotoxicity in a concentration-dependent manner? |
20624163 |
HL-60? |
Function Assay |
10 nM |
4/6/16 h |
induces the generation of hydrogen peroxide from 4h |
20624163 |
HP100 |
Function Assay |
10 nM |
4/6/16 h |
induces the generation of hydrogen peroxide from 4h |
20624163 |
HL-60? |
Function Assay |
10-500 nM |
4 h |
decreases the histone deacetylase (HDAC) activity? |
20624163 |
HP100 |
Function Assay |
10-500 nM |
4 h |
decreases the histone deacetylase (HDAC) activity? |
20624163 |
SKOV-3 |
Growth Inhibition Assay |
4/8/16 nM |
48 h |
inhibits cell growth in a concentration-dependent manner |
20404564 |
OVCAR-3 |
Growth Inhibition Assay |
4/8/16 nM |
48 h |
inhibits cell growth in a concentration-dependent manner |
20404564 |
HBL-2 |
Growth Inhibition Assay |
2-10 nM |
24 h |
IC50=4.3 nM |
20068080 |
Jeko-1 |
Growth Inhibition Assay |
2-50 nM |
24 h |
IC50=11 nM |
20068080 |
Granta-519 |
Growth Inhibition Assay |
5-40 nM |
24 h |
IC50=58.5 nM |
20068080 |
L1236 |
Cytotoxicity Assay |
1 nM-100 μM |
48 h |
EC50=0.07 μM |
19233470 |
L428 |
Cytotoxicity Assay |
1 nM-100 μM |
48 h |
EC50=0.43 μM |
19233470 |
KM-H2 |
Cytotoxicity Assay |
1 nM-100 μM |
48 h |
EC50=0.58 μM |
19233470 |
L540Cy |
Cytotoxicity Assay |
1 nM-100 μM |
48 h |
EC50=0.16 μM |
19233470 |
G401 |
Function Assay |
10 nM |
24/48/72 h |
increases CDKN1C expression |
19221586 |
STM91-01 |
Function Assay |
10 nM |
24/48/72 h |
increases CDKN1C expression |
19221586 |
SJSC? |
Function Assay |
10 nM |
24/48/72 h |
increases CDKN1C expression |
19221586 |
BT16? |
Function Assay |
10 nM |
24/48/72 h |
increases CDKN1C expression |
19221586 |
NCI-H23 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human NCI-H23 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
NCI-H522 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human NCI-H522 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
OVCAR5 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human OVCAR5 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
SW620 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human SW620 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
MDA-MB-435 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human MDA-MB-435 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
COLO205 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human COLO205 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
LOXIMVI |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human LOXIMVI cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
UACC62 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human UACC62 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
MDA-MB-231 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human MDA-MB-231 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
SF295 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human SF295 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
U251 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human U251 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
OVRAC3 |
Antitumor assay |
1.6 to 2.4 mg/kg |
up to 5 days |
Antitumor activity against human OVRAC3 cells implanted intraperitoneally in mouse assessed as inhibition of tumor cell growth at 1.6 to 2.4 mg/kg, ip administered on day 1 to 4 measured on day 5 by hollow fiber assay |
21967146 |
11z |
Kinase Assay |
3-100 nM |
|
reduces HDAC enzymatic activity (IC50?= 6.5 ± 0.6 nmol/L) |
20605144 |
ST486 |
Apoptosis Assay |
|
6 h |
induces extensive apoptosis |
23966164 |
Ramos |
Apoptosis Assay |
|
6 h |
induces extensive apoptosis |
23966164 |
DG75 |
Apoptosis Assay |
|
6 h |
induces no apoptosis |
23966164 |
CA46 |
Apoptosis Assay |
|
6 h |
induces blunt apoptosis |
23966164 |
U266 |
Growth Inhibition Assay |
|
24/48 h |
EC50s=10?nM; 48?h |
24030150 |
RPMI-8226 |
Growth Inhibition Assay |
|
24/48 h |
EC50s=1.8?nM; 48?h |
24030150 |
OPM-2 |
Growth Inhibition Assay |
|
24/48 h |
EC50s=1?nM; 48?h |
24030150 |
JJN3 |
Growth Inhibition Assay |
|
24/48 h |
EC50<1?nM; 48?h |
24030150 |
CD4 T |
Growth Inhibition Assay |
|
48 h |
CC50=107±126 nM |
24722454 |
CD4 T |
Growth Inhibition Assay |
|
48 h |
EC50=4.5±1.0 nM |
24722454 |
A498 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human A498 cells after 6 days by MTT assay, TGI = 0.028 μM. |
21967146 |
COLO205 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human COLO205 cells after 6 days by MTT assay, TGI = 0.031 μM. |
21967146 |
U251 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human U251 cells after 6 days by MTT assay, TGI = 0.031 μM. |
21967146 |
RXF393 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human RXF393 cells after 6 days by MTT assay, TGI = 0.062 μM. |
21967146 |
MDA-MB-468 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human MDA-MB-468 cells after 6 days by MTT assay, TGI = 0.09 μM. |
21967146 |
COLO205 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human COLO205 cells after 6 days by MTT assay, LC50 = 0.092 μM. |
21967146 |
UACC257 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human UACC257 cells after 6 days by MTT assay, TGI = 0.095 μM. |
21967146 |
U251 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human U251 cells after 6 days by MTT assay, LC50 = 0.13 μM. |
21967146 |
A498 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human A498 cells after 6 days by MTT assay, LC50 = 0.2 μM. |
21967146 |
NCI-H322M |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human NCI-H322M cells after 6 days by MTT assay, TGI = 0.23 μM. |
21967146 |
SF295 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human SF295 cells after 6 days by MTT assay, TGI = 0.25 μM. |
21967146 |
RXF393 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human RXF393 cells after 6 days by MTT assay, LC50 = 0.3 μM. |
21967146 |
NCI60 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human NCI60 cells after 6 days by MTT assay, TGI = 0.33 μM. |
21967146 |
SN12C |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human SN12C cells after 6 days by MTT assay, TGI = 0.34 μM. |
21967146 |
MDA-MB-231 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human MDA-MB-231 cells after 6 days by MTT assay, TGI = 0.35 μM. |
21967146 |
ACHN |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human ACHN cells after 6 days by MTT assay, TGI = 0.73 μM. |
21967146 |
SN12C |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human SN12C cells after 6 days by MTT assay, LC50 = 1.5 μM. |
21967146 |
UO31 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human UO31 cells after 6 days by MTT assay, TGI = 1.55 μM. |
21967146 |
Caki1 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human Caki1 cells after 6 days by MTT assay, TGI = 1.89 μM. |
21967146 |
NCI60 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human NCI60 cells after 6 days by MTT assay, LC50 = 3.5 μM. |
21967146 |
MDA-MB-231 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human MDA-MB-231 cells after 6 days by MTT assay, LC50 = 4.08 μM. |
21967146 |
MDA-MB-468 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human MDA-MB-468 cells after 6 days by MTT assay, LC50 = 4.14 μM. |
21967146 |
ACHN |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human ACHN cells after 6 days by MTT assay, LC50 = 5.37 μM. |
21967146 |
UACC257 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human UACC257 cells after 6 days by MTT assay, LC50 = 5.46 μM. |
21967146 |
NCI-H322M |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human NCI-H322M cells after 6 days by MTT assay, LC50 = 9.02 μM. |
21967146 |
SF295 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human SF295 cells after 6 days by MTT assay, LC50 = 10.2 μM. |
21967146 |
Caki1 |
Cytotoxicity assay |
|
6 days |
Cytotoxicity against human Caki1 cells after 6 days by MTT assay, LC50 = 20.9 μM. |
21967146 |
CD4+ T |
Function assay |
|
7 days |
Reactivation of latent HIV1 NL4-3-Luc expression in human naive CD4+ T cells treated 7 days post-infection measured after 48 hrs by luminescence plate reader analysis, EC50 = 0.003 μM. |
24495105 |
293T |
Function assay |
|
30 mins |
Inhibition of human HDAC1 expressed in human 293T cells using Ac-KGLGK(Ac)-MCA as substrate after 30 mins by fluorescence assay, IC50 = 0.0036 μM. |
24589486 |
293T |
Function assay |
|
30 mins |
Inhibition of mouse HDAC6 expressed in human 293T cells using Ac-KGLGK(Ac)-MCA as substrate after 30 mins by fluorescence assay, IC50 = 0.39 μM. |
24589486 |
mink Mv1Lu |
Function assay |
|
24 hrs |
Increase in human wild type p21 protein expression in mink Mv1Lu cells after 24 hrs by p21 promoter assay in presence of 0.1 mM dithiothreitol, EC1000 = 0.0157 μM. |
24997578 |
HCT116 |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HCT116 cells after 48 hrs in presence of DTT by MTT assay, IC50 = 0.003 μM. |
25147612 |
MOLT4 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MOLT4 cells after 72 hrs by CCK8 assay, GI50 = 0.00206 μM. |
26331334 |
DU145 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human DU145 cells after 72 hrs by CCK8 assay, GI50 = 0.00255 μM. |
26331334 |
U937 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human U937 cells after 72 hrs by CCK8 assay, GI50 = 0.00341 μM. |
26331334 |
HLF |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HLF cells after 72 hrs by CCK8 assay, GI50 = 0.00489 μM. |
26331334 |
WI38 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human WI38 cells after 72 hrs by CCK8 assay, GI50 = 0.00539 μM. |
26331334 |
U937 |
Function assay |
|
24 hrs |
Inhibition of HDAC6 in human U937 cells assessed as reduction of alpha-tubilin acetylation at 5 nM to 5 uM after 24 hrs by Western blot analysis |
26331334 |
HCT116 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HCT116 cells assessed as cell viability incubated for 72 hrs by coulter counter method, IC50 = 0.028 μM. |
26481659 |
IGROV1/Pt1 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human IGROV1/Pt1 cells assessed as cell viability incubated for 72 hrs by coulter counter method, IC50 = 0.08 μM. |
26481659 |
IGROV1 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human IGROV1 cells assessed as cell viability incubated for 72 hrs by coulter counter method, IC50 = 0.22 μM. |
26481659 |
CD4+ T |
Growth Inhibition Assay |
|
|
EC50=3 nM |
24495105 |
HuT-78 |
Growth Inhibition Assay |
|
|
IC50=1.73±0.44 nM |
24954856 |
H526 |
Growth Inhibition Assay |
|
|
IC50=0.15±0.03 nM |
24954856 |
H146 |
Growth Inhibition Assay |
|
|
IC50=0.22±0.07 nM |
24954856 |
EKVX |
Growth Inhibition Assay |
|
|
IC50=1.33±0.34 nM |
24954856 |
H460 |
Growth Inhibition Assay |
|
|
IC50=2.58±0.80 nM |
24954856 |
A549 |
Growth Inhibition Assay |
|
|
IC50=1.26±0.24 nM |
24954856 |
SF-295 |
Growth Inhibition Assay |
|
|
IC50=0.88±0.15 nM |
24954856 |
MDA-MB-435 |
Growth Inhibition Assay |
|
|
IC50=0.90±0.06 nM |
24954856 |
UACC-62 |
Growth Inhibition Assay |
|
|
IC50=0.56±0.16 nM |
24954856 |
LOX-IMVI |
Growth Inhibition Assay |
|
|
IC50=0.87±0.03 nM |
24954856 |
SW620 |
Growth Inhibition Assay |
|
|
IC50=0.93±0.29 nM |
24954856 |
S1 |
Growth Inhibition Assay |
|
|
IC50=7.67±0.29 nM |
24954856 |
HCT116-p21-/- |
Growth Inhibition Assay |
|
|
IC50=1.26±0.37 nM |
24954856 |
HCT116 |
Growth Inhibition Assay |
|
|
IC50=1.00±0.00 nM |
24954856 |
PC3 |
Growth Inhibition Assay |
|
|
IC50=1.65±0.35 nM |
24954856 |
MDA-MB-231 |
Growth Inhibition Assay |
|
|
IC50=0.68±0.14 nM |
24954856 |
SK-BR-3 |
Growth Inhibition Assay |
|
|
IC50=1.00±0.35 nM |
24954856 |
MCF-7 |
Growth Inhibition Assay |
|
|
IC50=1.10±0.20 nM |
24954856 |
MCF-10A |
Growth Inhibition Assay |
|
|
IC50=0.17±0.01 nM |
24954856 |
697? |
Growth Inhibition Assay |
|
|
IC50?=?2.5?nM |
21538216 |
697-R |
Growth Inhibition Assay |
|
|
IC50?=?8.6?nM? |
21538216 |
HUT78 |
Growth Inhibition Assay |
|
|
IC50=1 nM |
21198545 |
NCI-H1299 |
Growth Inhibition Assay |
|
|
IC50=4.6±0.2 ng/ml |
19179890 |
NCI-2882 |
Growth Inhibition Assay |
|
|
IC50=1.6±0.04 ng/ml |
19179890 |
HCC95 |
Growth Inhibition Assay |
|
|
IC50=2.5±0.05 ng/ml |
19179890 |
NCI-H23 |
Growth Inhibition Assay |
|
|
IC50=2.9±0.2 ng/ml |
19179890 |
NCI-H157 |
Growth Inhibition Assay |
|
|
IC50=1.6±0.02 ng/ml |
19179890 |
NCI-H460 |
Growth Inhibition Assay |
|
|
IC50=2.1±0.07 ng/ml |
19179890 |
NCI-H1975 |
Growth Inhibition Assay |
|
|
IC50=1.3±0.04 ng/ml |
19179890 |
NCI-H820 |
Growth Inhibition Assay |
|
|
IC50=2.4±0.1 ng/ml |
19179890 |
NCI-H1650 |
Growth Inhibition Assay |
|
|
IC50=4.9±0.3 ng/ml |
19179890 |
DTC1 |
Growth Inhibition Assay |
|
|
IC50=0.51 nM |
18566246 |
KAO |
Growth Inhibition Assay |
|
|
IC50=0.91 nM |
18566246 |
SU-CCS-1 |
Growth Inhibition Assay |
|
|
IC50=0.89 nM |
18566246 |
SYO-1 |
Growth Inhibition Assay |
|
|
IC50=0.67 nM |
18566246 |
FUJI |
Growth Inhibition Assay |
|
|
IC50=1.31 nM |
18566246 |
SKNMC |
Growth Inhibition Assay |
|
|
IC50=1.17 nM |
18566246 |
402-91 |
Growth Inhibition Assay |
|
|
IC50=1.26 nM |
18566246 |
1765-92 |
Growth Inhibition Assay |
|
|
IC50=1.77 nM |
18566246 |
JN-DSRCT-1 |
Growth Inhibition Assay |
|
|
IC50=1.25 nM |
18566246 |
NMS-2PC |
Growth Inhibition Assay |
|
|
IC50=0.81 nM |
18566246 |
HL60 |
Growth Inhibition Assay |
|
|
IC50=1.86 nM |
18566246 |
A549 |
Growth Inhibition Assay |
|
|
IC50=3.24 nM |
18566246 |
SW480 |
Growth Inhibition Assay |
|
|
IC50=2.69 nM |
18566246 |
MCF7 |
Growth Inhibition Assay |
|
|
IC50=3.55 nM |
18566246 |
PC-3 |
Growth Inhibition Assay |
|
|
IC50=2.51 nM |
18566246 |
MMRU |
Growth Inhibition Assay |
|
|
IC50=2.57 nM |
18566246 |
Hs68 |
Growth Inhibition Assay |
|
|
IC50=>10 nM |
18566246 |
hMSC-001F |
Growth Inhibition Assay |
|
|
IC50=>10 nM |
18566246 |
mammalian cells |
Function assay |
|
|
Inhibition of Histone deacetylase 4 in mammalian cells, IC50 = 0.51 μM. |
14584932 |
mammalian cells |
Function assay |
|
|
Inhibition of Histone deacetylase 1 induced acetylated histone in mammalian cells., EC50 = 36 μM. |
14584932 |
MCF7 |
Growth inhibition assay |
|
|
Growth inhibition of MCF7 cells, IC50 = 0.00075 μM. |
17958342 |
LLC |
Function assay |
|
|
Inhibition of HDAC-mediated HIF-1alpha activity in mouse LLC cells, IC50 = 2 μM. |
22305612 |
NCI-H522 |
Growth inhibition assay |
|
|
Growth inhibition of human NCI-H522 cells by sulforhodamine B colorimetric method, GI50 = 0.0018 μM. |
23313638 |
LOXIMVI |
Growth inhibition assay |
|
|
Growth inhibition of human LOXIMVI cells by sulforhodamine B colorimetric method, GI50 = 0.0025 μM. |
23313638 |
A549 |
Growth inhibition assay |
|
|
Growth inhibition of human A549 cells by sulforhodamine B colorimetric method, GI50 = 0.0026 μM. |
23313638 |
OVCAR5 |
Growth inhibition assay |
|
|
Growth inhibition of human OVCAR5 cells by sulforhodamine B colorimetric method, GI50 = 0.0028 μM. |
23313638 |
MKN74 |
Growth inhibition assay |
|
|
Growth inhibition of human MKN74 cells by sulforhodamine B colorimetric method, GI50 = 0.003 μM. |
23313638 |
NCI-H460 |
Growth inhibition assay |
|
|
Growth inhibition of human NCI-H460 cells by sulforhodamine B colorimetric method, GI50 = 0.003 μM. |
23313638 |
HCT116 |
Growth inhibition assay |
|
|
Growth inhibition of human HCT116 cells by sulforhodamine B colorimetric method, GI50 = 0.0031 μM. |
23313638 |
HCC2998 |
Growth inhibition assay |
|
|
Growth inhibition of human HCC2998 cells by sulforhodamine B colorimetric method, GI50 = 0.0031 μM. |
23313638 |
MKN1 |
Growth inhibition assay |
|
|
Growth inhibition of human MKN1 cells by sulforhodamine B colorimetric method, GI50 = 0.0032 μM. |
23313638 |
SKOV3 |
Growth inhibition assay |
|
|
Growth inhibition of human SKOV3 cells by sulforhodamine B colorimetric method, GI50 = 0.0033 μM. |
23313638 |
HT-29 |
Growth inhibition assay |
|
|
Growth inhibition of human HT-29 cells by sulforhodamine B colorimetric method, GI50 = 0.0033 μM. |
23313638 |
KM12 |
Growth inhibition assay |
|
|
Growth inhibition of human KM12 cells by sulforhodamine B colorimetric method, GI50 = 0.0034 μM. |
23313638 |
DMS114 |
Growth inhibition assay |
|
|
Growth inhibition of human DMS114 cells by sulforhodamine B colorimetric method, GI50 = 0.0036 μM. |
23313638 |
SF539 |
Growth inhibition assay |
|
|
Growth inhibition of human SF539 cells by sulforhodamine B colorimetric method, GI50 = 0.0036 μM. |
23313638 |
U251 |
Growth inhibition assay |
|
|
Growth inhibition of human U251 cells by sulforhodamine B colorimetric method, GI50 = 0.0039 μM. |
23313638 |
SF295 |
Growth inhibition assay |
|
|
Growth inhibition of human SF295 cells by sulforhodamine B colorimetric method, GI50 = 0.004 μM. |
23313638 |
MCF7 |
Growth inhibition assay |
|
|
Growth inhibition of human MCF7 cells by sulforhodamine B colorimetric method, GI50 = 0.0042 μM. |
23313638 |
NCI-H23 |
Growth inhibition assay |
|
|
Growth inhibition of human NCI-H23 cells by sulforhodamine B colorimetric method, GI50 = 0.0046 μM. |
23313638 |
OVCAR3 |
Growth inhibition assay |
|
|
Growth inhibition of human OVCAR3 cells by sulforhodamine B colorimetric method, GI50 = 0.0046 μM. |
23313638 |
MKN7 |
Growth inhibition assay |
|
|
Growth inhibition of human MKN7 cells by sulforhodamine B colorimetric method, GI50 = 0.0049 μM. |
23313638 |
SF268 |
Growth inhibition assay |
|
|
Growth inhibition of human SF268 cells by sulforhodamine B colorimetric method, GI50 = 0.0049 μM. |
23313638 |
MDA-MB-231 |
Growth inhibition assay |
|
|
Growth inhibition of human MDA-MB-231 cells by sulforhodamine B colorimetric method, GI50 = 0.0055 μM. |
23313638 |
OVCAR8 |
Growth inhibition assay |
|
|
Growth inhibition of human OVCAR8 cells by sulforhodamine B colorimetric method, GI50 = 0.0055 μM. |
23313638 |
DMS273 |
Growth inhibition assay |
|
|
Growth inhibition of human DMS273 cells by sulforhodamine B colorimetric method, GI50 = 0.0058 μM. |
23313638 |
DU145 |
Growth inhibition assay |
|
|
Growth inhibition of human DU145 cells by sulforhodamine B colorimetric method, GI50 = 0.006 μM. |
23313638 |
RXF631L |
Growth inhibition assay |
|
|
Growth inhibition of human RXF631L cells by sulforhodamine B colorimetric method, GI50 = 0.0066 μM. |
23313638 |
HBC4 |
Growth inhibition assay |
|
|
Growth inhibition of human HBC4 cells by sulforhodamine B colorimetric method, GI50 = 0.0069 μM. |
23313638 |
SNB75 |
Growth inhibition assay |
|
|
Growth inhibition of human SNB75 cells by sulforhodamine B colorimetric method, GI50 = 0.0072 μM. |
23313638 |
BSY1 |
Growth inhibition assay |
|
|
Growth inhibition of human BSY1 cells by sulforhodamine B colorimetric method, GI50 = 0.0085 μM. |
23313638 |
NCI-H226 |
Growth inhibition assay |
|
|
Growth inhibition of human NCI-H226 cells by sulforhodamine B colorimetric method, GI50 = 0.0089 μM. |
23313638 |
SNB78 |
Growth inhibition assay |
|
|
Growth inhibition of human SNB78 cells by sulforhodamine B colorimetric method, GI50 = 0.0096 μM. |
23313638 |
HBC5 |
Growth inhibition assay |
|
|
Growth inhibition of human HBC5 cells by sulforhodamine B colorimetric method, GI50 = 0.013 μM. |
23313638 |
MKN45 |
Growth inhibition assay |
|
|
Growth inhibition of human MKN45 cells by sulforhodamine B colorimetric method, GI50 = 0.014 μM. |
23313638 |
MKN28 |
Growth inhibition assay |
|
|
Growth inhibition of human MKN28 cells by sulforhodamine B colorimetric method, GI50 = 0.017 μM. |
23313638 |
PC3 |
Growth inhibition assay |
|
|
Growth inhibition of human PC3 cells by sulforhodamine B colorimetric method, GI50 = 0.018 μM. |
23313638 |
ACHN |
Growth inhibition assay |
|
|
Growth inhibition of human ACHN cells by sulforhodamine B colorimetric method, GI50 = 0.02 μM. |
23313638 |
OVCAR4 |
Growth inhibition assay |
|
|
Growth inhibition of human OVCAR4 cells by sulforhodamine B colorimetric method, GI50 = 0.02 μM. |
23313638 |
St-4 |
Growth inhibition assay |
|
|
Growth inhibition of human St-4 cells by sulforhodamine B colorimetric method, GI50 = 0.022 μM. |
23313638 |
HCT15 |
Growth inhibition assay |
|
|
Growth inhibition of human HCT15 cells by sulforhodamine B colorimetric method, GI50 = 0.45 μM. |
23313638 |
NCI-H522 |
Cytotoxicity assay |
|
|
Cytotoxicity against human NCI-H522 cells by SRB assay, GI50 = 0.0018 μM. |
24589486 |
LOXIMVI |
Cytotoxicity assay |
|
|
Cytotoxicity against human LOXIMVI cells by SRB assay, GI50 = 0.0025 μM. |
24589486 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells by SRB assay, GI50 = 0.0026 μM. |
24589486 |
OVCAR5 |
Cytotoxicity assay |
|
|
Cytotoxicity against human OVCAR5 cells by SRB assay, GI50 = 0.0028 μM. |
24589486 |
NCI-H460 |
Cytotoxicity assay |
|
|
Cytotoxicity against human NCI-H460 cells by SRB assay, GI50 = 0.003 μM. |
24589486 |
MKN74 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MKN74 cells by SRB assay, GI50 = 0.003 μM. |
24589486 |
HCC2998 |
Cytotoxicity assay |
|
|
Cytotoxicity against human HCC2998 cells by SRB assay, GI50 = 0.0031 μM. |
24589486 |
HCT116 |
Cytotoxicity assay |
|
|
Cytotoxicity against human HCT116 cells by SRB assay, GI50 = 0.0031 μM. |
24589486 |
MKN1 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MKN1 cells by SRB assay, GI50 = 0.0032 μM. |
24589486 |
HT-29 |
Cytotoxicity assay |
|
|
Cytotoxicity against human HT-29 cells by SRB assay, GI50 = 0.0033 μM. |
24589486 |
SKOV3 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SKOV3 cells by SRB assay, GI50 = 0.0033 μM. |
24589486 |
KM12 |
Cytotoxicity assay |
|
|
Cytotoxicity against human KM12 cells by SRB assay, GI50 = 0.0034 μM. |
24589486 |
SF539 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SF539 cells by SRB assay, GI50 = 0.0036 μM. |
24589486 |
DMS114 |
Cytotoxicity assay |
|
|
Cytotoxicity against human DMS114 cells by SRB assay, GI50 = 0.0036 μM. |
24589486 |
U251 |
Cytotoxicity assay |
|
|
Cytotoxicity against human U251 cells by SRB assay, GI50 = 0.0039 μM. |
24589486 |
SF295 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SF295 cells by SRB assay, GI50 = 0.004 μM. |
24589486 |
MCF7 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MCF7 cells by SRB assay, GI50 = 0.0042 μM. |
24589486 |
OVCAR3 |
Cytotoxicity assay |
|
|
Cytotoxicity against human OVCAR3 cells by SRB assay, GI50 = 0.0046 μM. |
24589486 |
NCI-H23 |
Cytotoxicity assay |
|
|
Cytotoxicity against human NCI-H23 cells by SRB assay, GI50 = 0.0046 μM. |
24589486 |
SF268 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SF268 cells by SRB assay, GI50 = 0.0049 μM. |
24589486 |
MKN7 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MKN7 cells by SRB assay, GI50 = 0.0049 μM. |
24589486 |
OVCAR8 |
Cytotoxicity assay |
|
|
Cytotoxicity against human OVCAR8 cells by SRB assay, GI50 = 0.0055 μM. |
24589486 |
MDA-MB-231 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MDA-MB-231 cells by SRB assay, GI50 = 0.0055 μM. |
24589486 |
DMS273 |
Cytotoxicity assay |
|
|
Cytotoxicity against human DMS273 cells by SRB assay, GI50 = 0.0058 μM. |
24589486 |
DU145 |
Cytotoxicity assay |
|
|
Cytotoxicity against human DU145 cells by SRB assay, GI50 = 0.006 μM. |
24589486 |
RXF631L |
Cytotoxicity assay |
|
|
Cytotoxicity against human RXF631L cells by SRB assay, GI50 = 0.0066 μM. |
24589486 |
HBC4 |
Cytotoxicity assay |
|
|
Cytotoxicity against human HBC4 cells by SRB assay, GI50 = 0.0069 μM. |
24589486 |
SNB75 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SNB75 cells by SRB assay, GI50 = 0.0072 μM. |
24589486 |
BSY1 |
Cytotoxicity assay |
|
|
Cytotoxicity against human BSY1 cells by SRB assay, GI50 = 0.0085 μM. |
24589486 |
NCI-H226 |
Cytotoxicity assay |
|
|
Cytotoxicity against human NCI-H226 cells by SRB assay, GI50 = 0.0089 μM. |
24589486 |
SNB78 |
Cytotoxicity assay |
|
|
Cytotoxicity against human SNB78 cells by SRB assay, GI50 = 0.0096 μM. |
24589486 |
HBC5 |
Cytotoxicity assay |
|
|
Cytotoxicity against human HBC5 cells by SRB assay, GI50 = 0.013 μM. |
24589486 |
MKN45 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MKN45 cells by SRB assay, GI50 = 0.014 μM. |
24589486 |
MKN28 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MKN28 cells by SRB assay, GI50 = 0.017 μM. |
24589486 |
PC3 |
Cytotoxicity assay |
|
|
Cytotoxicity against human PC3 cells by SRB assay, GI50 = 0.018 μM. |
24589486 |
ACHN |
Cytotoxicity assay |
|
|
Cytotoxicity against human ACHN cells by SRB assay, GI50 = 0.02 μM. |
24589486 |
OVCAR4 |
Cytotoxicity assay |
|
|
Cytotoxicity against human OVCAR4 cells by SRB assay, GI50 = 0.02 μM. |
24589486 |
St-4 |
Cytotoxicity assay |
|
|
Cytotoxicity against human St-4 cells by SRB assay, GI50 = 0.022 μM. |
24589486 |
HCT15 |
Cytotoxicity assay |
|
|
Cytotoxicity against human HCT15 cells by SRB assay, GI50 = 0.45 μM. |
24589486 |